Psychopharmacological Properties of Ptychopetalum Olacoides bentham (Olacaceae)

REFERENCES

• Ahmed A, Marshall BB (1962): Relationship between anti acetylcholine and antitremorine activity in anti-Parkin-sonian and related drugs. Br J Pharmacol 18: 247–254.
   Google Scholar
• Bandoni AL, Mendiondo ME, Rondina RVD, Coussio JD (1972): Survey of Argentine medicinal plants — folklore and phytochemical screening. Lloydia 35: 69–80.
   PubMedGoogle Scholar
• Birkmayer W, Riederer P (1983): Parkinson's disease: bio-chemistry, clinical pathology, and treatment. Springer-Verlag, New York.
   Google Scholar
• Blier P, Montigny C (1994): Current advances and trends in the treatment of depression. Trends Pharmacol Sc 15: 220–226.
   PubMed Web of Science ®Google Scholar
• Bourin M, Poncelet M, Chermat R, Simon P (1983): The Value of the Reserpine Test in Psychopharmacology. Drug Res 33: 1173–1176.
   PubMed Web of Science ®Google Scholar
• Bourin M, Poisson L, Larousse C (1986): Piracetam interac-tion with neuroleptics in psychopharmacological tests. Neuropsychobiology 19: 93–96.
   Google Scholar
• Buffun J (1982): Pharmacosexology: the effects of drugs on sexual function. J Psychoactive Drugs 14: 5–41.
   PubMed Web of Science ®Google Scholar
• Campanella Get al. (1987): drugs affecting movement disor-ders. Ann Rev Pharmacol Toxicol 27: 113–136.
   PubMed Web of Science ®Google Scholar
• Costa AF (1972): Farmacognosia. vol 3. Fund. Calouste Gul-benkian, Lisboa.
   Google Scholar
• Dandiya PC, Menon MK (1965): Interaction of asarone with mescaline, amphetamine and tremorine. Life Sci 4: 1635–1641.
   PubMedGoogle Scholar
• DeFeudis FV (1991): In vivo studies with Egb 761. In: Ginkgo biloba Extract (EGb 761): Pharmacological Activities and Clinical Applications, 61-96 pp., Elsevier, Paris.
   Google Scholar
• Dickinson SL, Curzon G (1983): Roles of dopamine and 5-hydroxytryptamine in stereotyped and non-stereotyped behaviour. Neuropharmacology 22: 805–812.
   PubMed Web of Science ®Google Scholar
• Dickinson SL, Gadie B, Tulloch IF (1988): a- and a2-adrenoceptor antagonists differentially inflence locomotor and stereotyped behaviour induced by d-amphetamine and apomorphine in the rat. Psychopharmacology 96: 521–527.
   PubMed Web of Science ®Google Scholar
• Duke JA (1992a): Handbook of Phytochemical Constituents of GRAS Herbs and Other Economic Plants. CRC Press, Boca Raton, FL.
   Google Scholar
• Duke JA (1992b): Handbook of biologically active phyto-chemicals and their activities. CRC Press, Boca Raton, FL.
   Google Scholar
• Elisabetsky E (1987): From indigenous disease concepts to laboratory work hypothesis: The case of "nerve tonics" from the Brazilian Amazon. International Foundation for Science, Provisional Report Series, IFS, Grey Turegatan 19, S-11438, Stockholm, Sweden.
   Google Scholar
• Elisabetsky E, Setzer R (1985): Caboclo concepts of disease diagnosis and therapy: implications for ethnopharmacol-ogy and health systems in Amazonia. In: Parker EP, eds., The Amazon Caboclo: historical and contemporary per-spectives 32: 243–278, Williamsburgh: Studies on Third World Societies Publication Series.
   Google Scholar
• Elisabetsky E, Figueiredo W, Oliveira G (1992): Traditional Amazonian nerve tonics as antidepressant agents: Chaunochiton kappleri: a case study. J Herbs Spices, Med Plants]: 125–161.
   Google Scholar
• Ellenbroek BA (1993): Treatment of schizophrenia: a clini-cal and preclinical evaluation of neuroleptic drugs. Phar-macol & Therapeut 57: 1–78.
   PubMed Web of Science ®Google Scholar
• Fibiger HC (1984): The neurobiological substrates of depres-sion in Parkinson's disease: a hypothesis. Can J Neurolog Sc]]: 105–107.
   Google Scholar
• Foreman MM, Gehlert DR, Schaus JM (1995): Quinelorane, a potent and selective dopamine agonist for the "D2-like" receptor family. Neurotransmissions 11: 1–5.
   Google Scholar
• Forgacs P, Jacquemin H, Moretti C, Provost J, Touche A (1983): Phytochemical and biological activity studies on 18 plants from French Guyana. Plant Med Phytothér 17: 22–32.
   Google Scholar
• Grenand P, Moretti C, Jacquemin H (1987): Pharmacopées traditionnelles en Guyane. Editions de L'Orstom, France.
   Google Scholar
• Holohean AH, White FJ, Appel JB (1982): Dopaminergic and serotoninergic mediation of the discriminable effects of ergot alkaloids. Eur J Pharmacol 81: 595–602.
   PubMed Web of Science ®Google Scholar
• Hyman SE, Nestler EJ (1996): Initiation and adaptation: a paradigm for understanding psychotropic drug action. Amer J Psych 152: 151–162.
   Google Scholar
• Jackson DM, Westlind-Danielsson A (1994): Dopamine receptors: molecular biology, biochemistry and behav-ioural aspects. Pharmacol Therap 64: 291–369.
   PubMed Web of Science ®Google Scholar
• Le Moal M (1995): Mesocorticolimbic dopaminergic neu-rons: functional and regulatory roles. In: Bloom F, Kupfer DJ, eds., Psychopharmacology: the fourth generation of progress. New York, Raven Press, pp. 283–293.
   Google Scholar
• Leonard BE (1986): Mechanism of action of antidepressants: relevance to understanding the psychobiology of depres-sion? Clin Neuropharmacol 9: 67–69.
   Google Scholar
• Malick JB (1983): Potentiation of Yohimbine-induced lethal-ity in mice: predictor of antidepressant potential. Drug Dev Res 3: 357–363.
   Google Scholar
• Malone MH (1983): The pharmacological evaluation of nat-ural products — general and specific approaches to screen-ing ethnopharmaceuticals. J Ethnopharmacol 8: 127–147.
   PubMed Web of Science ®Google Scholar
• Männisto PT et al. (1995): Beneficial effects of co-administration of catechol-O-methyltransferase inhibitors and L-dihydroxyphenylanine in rat models of depression. Eur J Pharmacol 274: 229–233.
   PubMed Web of Science ®Google Scholar
• Matos FSA (1988): Introducdo a Fitoquimica Experimental, 126 pp., Ed. Universidade Federal do Cearn, Fortaleza.
   Google Scholar
• Nakachi et al. (1995): Effects of various dopamine uptake inhibitors on striatal extracellular dopamine levels and behaviours in rats. Eur J Pharmacol 281: 195–203.
   PubMed Web of Science ®Google Scholar
• Oates JA (1996): Antihypertensive agents and drug therapy of hypertension. In: Goodman LS, Gilman A, and Gilman, AG, eds., Pharmacological basis of therapeutics, New York, Pergamon, pp. 781–808.
   Google Scholar
• Polansky J, Prangé T, Pascard C (1984): Structure (X-ray analysis) of manicoline B, a mixture of two diastereoiso-mers of a new alkaloid from Dulacia guianensis (01a-caceae). Tetrahedron Letters 25: 2359–2362.
   Google Scholar
• Quiton RM (1963): The increase in the toxicity induced by imipramine and other drugs in mice. Brit J Pharmacol Chemother 21: 51–66.
   PubMed Web of Science ®Google Scholar
• Sleumer HO (1984): Flora Neotropica, The New York Botan-ical Garden, New York, 159pp.
   Google Scholar
• Steinmetz EF (1962): Muira puama ("potency wood"). Quart J Crude Drug Res 2: 229–232.
   Google Scholar
• Uber Bucek E, Fournier G, Dadoun H (1987): Volatile con-stituents of Ptychopetalum olacoides root oil. Planta Med 53: 231.
   PubMed Web of Science ®Google Scholar
• Waddington JL, Gamble SJ (1980): Differential effect of age-ing on distinct features of apomorphine stereotypy in the adult rat. Neuroscience Letters 20: 95–99.
   PubMed Web of Science ®Google Scholar
• Wagner H, Non H, Winterhoff H (1994): Plant Adaptogens, Phytomedicine 1: 63–76.
   Google Scholar
• Willner P (1984): The validity of animal models of depres-sion. Psychopharmacol 83: 1–16.
   PubMed Web of Science ®Google Scholar
• Willner P (1990): Animal models of depression: an overview. Pharmacol Therap 45: 425–455.
   PubMed Web of Science ®Google Scholar